BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $45,000 | -76.1% | 43,334 | -60.7% | 0.00% | – |
Q2 2019 | $188,000 | -42.0% | 110,367 | +14.9% | 0.00% | – |
Q1 2019 | $324,000 | -70.4% | 96,024 | -74.4% | 0.00% | -100.0% |
Q4 2018 | $1,096,000 | -70.6% | 375,372 | -38.1% | 0.00% | -60.0% |
Q3 2018 | $3,734,000 | -31.1% | 606,162 | -17.4% | 0.01% | -28.6% |
Q2 2018 | $5,416,000 | +235.8% | 733,850 | +198.5% | 0.01% | +250.0% |
Q1 2018 | $1,613,000 | +54.4% | 245,868 | +97.9% | 0.00% | +100.0% |
Q4 2017 | $1,045,000 | -30.0% | 124,260 | -2.8% | 0.00% | -66.7% |
Q2 2017 | $1,493,000 | +5.2% | 127,839 | +11.2% | 0.00% | 0.0% |
Q1 2017 | $1,419,000 | +144.2% | 115,010 | +169.8% | 0.00% | +200.0% |
Q4 2016 | $581,000 | -77.5% | 42,633 | -84.6% | 0.00% | -83.3% |
Q1 2016 | $2,580,000 | -70.3% | 275,982 | -35.7% | 0.01% | -66.7% |
Q4 2015 | $8,700,000 | -39.7% | 429,188 | -56.8% | 0.02% | -35.7% |
Q3 2015 | $14,423,000 | +28.8% | 992,616 | +88.5% | 0.03% | +33.3% |
Q2 2015 | $11,200,000 | +86.0% | 526,583 | +102.6% | 0.02% | +90.9% |
Q1 2015 | $6,021,000 | +143.9% | 259,861 | +142.5% | 0.01% | +120.0% |
Q4 2014 | $2,469,000 | – | 107,162 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|